107 related articles for article (PubMed ID: 6572777)
1. Prolonged second remissions in childhood acute lymphocytic leukemia: a report from the Childrens Cancer Study Group.
Baum E; Nachman J; Ramsay N; Weetman B; Neerhout R; Littman P; Griffin T; Norris D; Sather H
Med Pediatr Oncol; 1983; 11(1):1-7. PubMed ID: 6572777
[TBL] [Abstract][Full Text] [Related]
2. Equivalence of intrathecal chemotherapy and radiotherapy as central nervous system prophylaxis in children with acute lymphatic leukemia: a pediatric oncology group study.
Sullivan MP; Chen T; Dyment PG; Hvizdala E; Steuber CP
Blood; 1982 Oct; 60(4):948-58. PubMed ID: 6956376
[TBL] [Abstract][Full Text] [Related]
3. Favorable response to maintenance therapy of second or subsequent remissions in childhood acute lymphocytic leukemia.
Kimball JC; Herson J; Sullivan MP
Cancer; 1980 Sep; 46(5):1093-7. PubMed ID: 6938300
[TBL] [Abstract][Full Text] [Related]
4. Modified Capizzi maintenance regimen in children with relapsed acute lymphoblastic leukaemia.
Pinkerton CR; Mills S; Chessells JM
Med Pediatr Oncol; 1986; 14(2):69-72. PubMed ID: 3458998
[TBL] [Abstract][Full Text] [Related]
5. Methotrexate and asparaginase combination chemotherapy in refractory acute lymphoblastic leukemia of childhood.
Lobel JS; O'Brien RT; McIntosh S; Aspnes GT; Capizzi RL
Cancer; 1979 Mar; 43(3):1089-94. PubMed ID: 284840
[TBL] [Abstract][Full Text] [Related]
6. Treatment of acute lymphoblastic leukemia in relapse: efficacy of a four-drug reinduction regimen.
Poplack DG; Reaman GH; Wesley R
Cancer Treat Rep; 1981; 65 Suppl 4():93-6. PubMed ID: 6955015
[TBL] [Abstract][Full Text] [Related]
7. L-Asparaginase, vincristine, and prednisone for induction of first remission in acute lymphocytic leukemia.
Ortega JA; Nesbit ME; Donaldson MH; Hittle RE; Weiner J; Karon M; Hammond D
Cancer Res; 1977 Feb; 37(2):535-40. PubMed ID: 264412
[TBL] [Abstract][Full Text] [Related]
8. Vincristine and prednisone vs vincristine, L-asparaginase, and prednisone for second remission induction of acute lymphocytic leukemia in children.
Herson J; Starling KA; Dyment PG; Humphrey GB; Pullen J; Vats T
Med Pediatr Oncol; 1979; 6(4):317-23. PubMed ID: 384187
[TBL] [Abstract][Full Text] [Related]
9. Effective dose of L-asparaginase for induction of remission in previously treated children with acute lymphocytic leukemia: a report from Childrens Cancer Study Group.
Ertel IJ; Nesbit ME; Hammond D; Weiner J; Sather H
Cancer Res; 1979 Oct; 39(10):3893-6. PubMed ID: 383278
[TBL] [Abstract][Full Text] [Related]
10. Combination chemotherapy for marrow relapse in children and adolescents with acute lymphocytic leukaemia.
Amadori S; Spiriti MA; Meloni G; Pacilli L; Papa G; Mandelli F
Scand J Haematol; 1981 Apr; 26(4):292-6. PubMed ID: 6950494
[TBL] [Abstract][Full Text] [Related]
11. L-asparaginase used with cytosine arabinoside in treatment of childhood acute lymphocytic leukemia refractory to vincristine and prednisone.
Smithson WA; Gilchrist GS; Burgert EO
Med Pediatr Oncol; 1979; 6(2):163-70. PubMed ID: 287856
[TBL] [Abstract][Full Text] [Related]
12. Combination therapy with methotrexate, vincristine, polyethylene-glycol conjugated-asparaginase, and prednisone in the treatment of patients with refractory or recurrent acute lymphoblastic leukemia.
Aguayo A; Cortes J; Thomas D; Pierce S; Keating M; Kantarjian H
Cancer; 1999 Oct; 86(7):1203-9. PubMed ID: 10506705
[TBL] [Abstract][Full Text] [Related]
13. Improved disease-free survival of children with acute lymphoblastic leukemia at high risk for early relapse with the New York regimen--a new intensive therapy protocol: a report from the Childrens Cancer Study Group.
Steinherz PG; Gaynon P; Miller DR; Reaman G; Bleyer A; Finklestein J; Evans RG; Meyers P; Steinherz LJ; Sather H
J Clin Oncol; 1986 May; 4(5):744-52. PubMed ID: 3517244
[TBL] [Abstract][Full Text] [Related]
14. Combination chemotherapy in relapsed childhood acute lymphoblastic leukemia.
Amato KR; Sallan SE; Lipton JM
Cancer Treat Rep; 1984 Feb; 68(2):411-2. PubMed ID: 6583001
[TBL] [Abstract][Full Text] [Related]
15. Methotrexate/L-asparaginase combination chemotherapy for patients with acute leukemia in relapse: a study of 36 children.
Harris RE; McCallister JA; Provisor DS; Weetman RM; Baehner RL
Cancer; 1980 Nov; 46(9):2004-8. PubMed ID: 6968621
[TBL] [Abstract][Full Text] [Related]
16. Three versus five years of maintenance therapy are equivalent in childhood acute lymphoblastic leukemia: a report from the Childrens Cancer Study Group.
Miller DR; Leikin SL; Albo VC; Sather H; Hammond GD
J Clin Oncol; 1989 Mar; 7(3):316-25. PubMed ID: 2645385
[TBL] [Abstract][Full Text] [Related]
17. Moderate dose methotrexate, vincristine, asparaginase, and dexamethasone for treatment of adult acute lymphocytic leukemia.
Esterhay RJ; Wiernik PH; Grove WR; Markus SD; Wesley MN
Blood; 1982 Feb; 59(2):334-45. PubMed ID: 7034815
[TBL] [Abstract][Full Text] [Related]
18. Combination chemotherapy for bone marrow relapse in childhood lymphoblastic leukaemia (ALL).
Chessells JM; Cornbleet M
Med Pediatr Oncol; 1979; 6(4):359-65. PubMed ID: 289904
[TBL] [Abstract][Full Text] [Related]
19. Repetitive low dose oral methotrexate and intravenous mercaptopurine treatment for patients with lower risk B-lineage acute lymphoblastic leukemia. A Pediatric Oncology Group pilot study.
Mahoney DH; Camitta BM; Leventhal BG; Shuster JJ; Civin CJ; Ganick DJ; Lauer SJ; Steuber CP; Kamen BA
Cancer; 1995 May; 75(10):2623-31. PubMed ID: 7736409
[TBL] [Abstract][Full Text] [Related]
20. Therapy of refractory adult acute lymphoblastic leukemia with vincristine and prednisone plus tandem methotrexate and L-asparaginase. Results of a Cancer and Leukemia Group B Study.
Terebelo HR; Anderson K; Wiernik PH; Cuttner J; Cooper RM; Faso L; Berenberg JL
Am J Clin Oncol; 1986 Oct; 9(5):411-5. PubMed ID: 3465228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
